#NAION
עושה רושם שעיתון "הארץ" ממשיך בהתדרדרות בלתי פוסקת למחוזות הטמקא. לא, "הארץ", הם לא מוכנים לוותר על הראייה; הסיכון ע"פ ה-FDA הוא 0.0064%, וזה עוד לפני שלקחנו בחשבון את ההשפעות המזיקות של השמנת יותר ואולי גם הקשר בין קומורבידיות והפגיעה בראיה (שנקראת NAION).
November 17, 2026 at 7:55 PM
Yes, Diabetes can cause Diabetic Retinopathy, and it can also cause NAION, too.
November 18, 2026 at 8:07 AM
NAION — NAION is caused by reduced blood flow to the optic nerve. It is a common cause of acute optic nerve injury in adults >50 years old (incidence is 2.3-10.2 cases per 100,000 person-years).
November 16, 2026 at 11:47 PM
Dani is having a very stressful day, on multiple fronts, and desperately needs to relax.
So time for Gunpla Therapy!!
Today Dani will be assembling Naion and hopefully avoiding losing her mind.
November 12, 2026 at 10:33 PM
Almost done
November 13, 2026 at 12:26 AM
November 16, 2026 at 11:05 PM
FDA updates side effect listings for GLP-1 RA based drugs. Learn more about the risks with MNB medicalnewsbulletin.com/glp-1-based-... 🧪 🩺 medsky #GLP1Community #fitfam #weightloss #DiabetesManagement
FDA to Add Vision Loss Warning to GLP-1 Drugs | Medical News Bulletin
FDA issues vision warning for GLP-1 Receptor Agonist drugs like Ozempic, Zepbound, after increase in reports of NAION. Learn more with MNB.
medicalnewsbulletin.com
November 17, 2026 at 4:19 PM
Naion is such a great kit!
November 13, 2026 at 1:46 AM
What the FDA's class-wide GLP-1 NAION warning means for manufacturers, telehealth and compounding sellers, advertisers and employer health plans.
FDA’s class-wide GLP-1 NAION warning: legal and compliance ripple effects
What the FDA's class-wide GLP-1 NAION warning means for manufacturers, telehealth and compounding sellers, advertisers and employer health plans.
kurums.com
November 16, 2026 at 6:24 AM
Dani finished Gundam Naion, she was such a fun and unique build!!!
Not to mention she turned out beautiful!! 💕 💞
Very happy with this build all around 😸🎉
November 13, 2026 at 1:14 AM
Patients typically present with sudden, painless vision loss in one eye, accompanied by reduced visual acuity and visual field defects. Vision loss can be permanent. Patients with a history of NAION are at increased risk of recurrence.
November 16, 2026 at 11:47 PM
Patients with suspected NAION should be promptly referred to an ophthalmologist; the benefits of continuing a GLP-1 receptor agonist should be weighed against the risk of NAION. The American Academy of Ophthalmology and North American Neuro-Ophthalmology Society support the FDA's recommendations.
November 16, 2026 at 11:59 PM
MECHANISM — The mechanism by which GLP-1 receptor agonists increase the risk of NAION is unclear. It may involve rapid correction of hyperglycemia, but patients receiving GLP-1 receptor agonists usually have NAION risk factors, such as diabetes, obesity, cardiovascular disease, hypertension,
November 16, 2026 at 11:50 PM
I'll save you the click through to the fascist rag: should the Non-arteritic anterior ischemic optic neuropathy (NAION) warning concern you? No.

6 cases / 100k people / year in those on GLP-1.
4 cases/ 100k people / year in those on placebo.
The FDA issued updated rules on GLP-1 medications Monday and will now require manufacturers to warn on labels that the drugs can potentially increase the risk of vision loss.

Should you worry? Here’s what ophthalmology experts say:
The FDA has a new warning about GLP-1s and vision loss. Should you worry?
More research is needed to determine if GLP-1s are definitely linked to ‘eye stroke.’
www.washingtonpost.com
November 11, 2026 at 5:04 AM
The FDA is requiring that a warning about a risk of nonarteritic anterior ischemic optic neuropathy (NAION) be added to the package inserts of the GLP-1 receptor agonists dulaglutide (Trulicity), exenatide, liraglutide (Saxenda, Victoza), semaglutide (Ozempic, Rybelsus, Wegovy),
November 16, 2026 at 11:45 PM
Ophthopedia Update: Peripapillary microvascular characteristics in non-arteritic anterior ischaemic optic neuropathy and optic neuritis: Introduction

Although non-arteritic anterior ischaemic optic neuropathy (NAION) and optic neuritis have distinct… #Ophthalmology #Ophthotwitter #BJO
Peripapillary microvascular characteristics in non-arteritic anterior ischaemic optic neuropathy and optic neuritis
Introduction Although non-arteritic anterior ischaemic optic neuropathy (NAION) and optic neuritis have distinct pathophysiologies, clinical findings may overlap. Of particular interest is optic disc swelling, which is relatively common in optic neuritis among Asian populations,1 making differentiation from NAION challenging. NAION results from acute ischaemia of the optic nerve head secondary to transient blood flow slowing in the posterior ciliary arteries (PCAs).2 As choroidal circulation is supplied by the PCAs, outer retinal complex and choriocapillaris (ORCC) vessel density (VD) may reflect acute ischaemic changes in the PCAs.3 Previous studies have reported reduced peripapillary VD in both NAION and optic neuritis, particularly in the radial peripapillary capillary layer.4 5 However, this parameter may be affected by optic disc swelling and may not reflect PCA-related circulation.3 6 To the best of our knowledge, no studies have reported ORCC VD in...
dlvr.it
November 17, 2026 at 5:50 PM
From the article:

NAION), is rare, and a causal relationship has not been established.
November 10, 2026 at 5:06 PM
Hey, so it turns out GLP-1 medications can cause blindness.

I’m on Ozempic, which has been an incredible help to me. It has treated my insulin resistance so I actually experience feeling full, and I’ve lost weight.

#Diabetes #Disabled #Ozempic #Wegovy #Mounjaro #Zepbound #Soliqua
November 18, 2026 at 12:00 AM
It me, I've been in the big trouble, there, (I didn't have PML, I'm not dead, yay. Really no hospital I'd rather be at with potential big eye problems.)

what increases risk of NAION? diabetes, hypertension, hyperlipidemia, sleep apnea. so the cause/effect interplay here is ... complex.
November 11, 2026 at 5:22 AM
"While many report a small possible increased risk of NAION in patients taking GLP-1 RAs such as semaglutide, some studies report no correlation, and the overall magnitude of the risk of NAION remains low" You know what else causes blindness diabetes and strokes.
November 10, 2026 at 5:12 PM
BASIS FOR NEW WARNING — NAION has been reported with all currently available GLP-1 receptor agonists. The new warning was based on the results of a FDA-conducted metaanalysis of 126 randomized controlled trials that
November 16, 2026 at 11:53 PM
[November 13, 2026] US FDA has ordered drugmakers to add a warning to GLP-1s about a possible link to a rare eye condition, NAION.
www.resetera.com/threads/16...
November 15, 2026 at 4:44 PM
FDA is ordering a class-wide labeling change for all GLP-1 drugs (Ozempic, Wegovy, Mounjaro, Zepbound and 8 more): a new Warnings note on NAION, a rare cause of sudden vision loss.
→ https://www.cybereyeq.com/?utm_source=bluesky&utm_medium=social&utm_campaign=social-daily
November 17, 2026 at 11:46 PM